TLR7 and neoplasm: The TLR7 ligand agonist (imiquinod) has been combined with radiation in a mouse model of skin metastases from breast cancer.49 Primary and secondary sites were injected with breast cancer cells and tumor growth was suppressed at both sites when imiquinod was applied topically to the primary site alone (reduction of tumor volumes).